Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Learn more about the scientific background of the most common genome editing tools, and the evolving genome editing market ...

A recent study showcases the power of CRISPR gene editing to significantly boost the production of resveratrol, a ...

Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...

CRISPR Therapeutics (NASDAQ:CRSP) shares snapped six straight sessions of losses on Wednesday, as the stock closed 3% to $34.18. The Switzerland-based biotech company lost about 19% in the preceding ...

KLP Kapitalforvaltning AS purchased a new position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the ...

Bullish option flow detected in Crispr Therapeutics (CRSP) with 4,723 calls trading, 2x expected, and implied vol increasing over 3 points to ...

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

Learn more about whether Alvotech or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which ...

Corient Private Wealth LLC lessened its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.0% during the ...